|
US4783443A
(en)
|
1986-03-03 |
1988-11-08 |
The University Of Chicago |
Amino acyl cephalosporin derivatives
|
|
US5844092A
(en)
|
1994-03-18 |
1998-12-01 |
Genentech, Inc. |
Human TRK receptors and neurotrophic factor inhibitors
|
|
US5877016A
(en)
|
1994-03-18 |
1999-03-02 |
Genentech, Inc. |
Human trk receptors and neurotrophic factor inhibitors
|
|
US6677135B1
(en)
|
1996-05-08 |
2004-01-13 |
Biogen, Inc. |
Ret ligand (RetL) for stimulating neutral and renal growth
|
|
DE69736428T2
(de)
|
1996-05-08 |
2007-08-30 |
Biogen Idec Ma Inc., Cambridge |
RET-LIGAND 3 (RetL3), UM NEURALES UND RENALES WACHSTUM ZU STIMULIEREN
|
|
US6682921B1
(en)
|
1996-08-21 |
2004-01-27 |
New York University |
Crystals of the tyrosine kinase domain of non-insulin receptor tyrosine kinases
|
|
US6531152B1
(en)
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
|
WO2001016169A2
(en)
|
1999-09-01 |
2001-03-08 |
Biogen, Inc. |
RET LIGAND 5 (Retl5) FROM HUMAN AND MOUSE
|
|
FI20000403A0
(fi)
|
2000-02-22 |
2000-02-22 |
Hannu Sariola |
GDNF perhesukuisten yhdisteiden käyttö kivessyövän hoitoon tarkoitettujen tuotteiden valmistamiseksi
|
|
MXPA02012602A
(es)
|
2000-06-22 |
2003-05-14 |
Genentech Inc |
Anticuerpos monoclonales agonistas anti-trk-c.
|
|
AU2002334355A1
(en)
|
2001-09-06 |
2003-03-18 |
Prochon Biotech Ltd. |
Protein tyrosine kinase inhibitors
|
|
PE20030762A1
(es)
|
2001-12-18 |
2003-09-05 |
Schering Corp |
Compuestos heterociclicos como antagonistas nk1
|
|
US7466344B2
(en)
|
2002-06-07 |
2008-12-16 |
Scimeasure Analytical Systems, Inc. |
High-speed low noise CCD controller
|
|
ITMI20021620A1
(it)
|
2002-07-23 |
2004-01-23 |
Novuspharma Spa |
Composto ad ativita' antitumorale
|
|
JP2005535675A
(ja)
|
2002-07-24 |
2005-11-24 |
ユニバーシティ・オブ・シンシナティ |
変異型ｒｅｔキナーゼ関連疾患を処置するための４−（４−メチルピペラジン−１−イルメチル）−ｎ−［４−メチル−３−（４−ピリジン−３−イル）ピリミジン−２−イルアミノ］フェニル］−ベンズアミド
|
|
DE602004021472D1
(en)
|
2003-02-20 |
2009-07-23 |
Smithkline Beecham Corp |
Pyrimiidinverbindungen
|
|
US20090143399A1
(en)
|
2003-10-14 |
2009-06-04 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Protein Kinase Inhibitors
|
|
WO2005044835A1
(en)
|
2003-10-27 |
2005-05-19 |
Genelabs Technologies, Inc. |
METHODS FOR PREPARING 7-(2'-SUBSTITUTED-ß-D-RIBOFURANOSYL)-4-(NR2R3)-5-(SUBSTITUTED ETHYN-1-YL)-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES
|
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
|
PT1687305E
(pt)
|
2003-11-21 |
2008-10-17 |
Novartis Ag |
Derivados de 1h-imidazoquinolina como inibidores de proteína quinase
|
|
BRPI0416935A
(pt)
|
2003-11-28 |
2007-01-16 |
Novartis Ag |
derivados de diaril ureia no tratamento de doenças dependentes de quìnase de proteìna
|
|
DK1696920T3
(en)
|
2003-12-19 |
2015-01-19 |
Plexxikon Inc |
RELATIONS AND PROCEDURES FOR THE DEVELOPMENT OF LAW MODULATORS
|
|
GB0330042D0
(en)
|
2003-12-24 |
2004-01-28 |
Pharmacia Italia Spa |
Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them
|
|
GB0330043D0
(en)
|
2003-12-24 |
2004-01-28 |
Pharmacia Italia Spa |
Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them
|
|
WO2005068424A1
(en)
|
2004-01-20 |
2005-07-28 |
Cell Therapeutics Europe S.R.L. |
Indolinone derivatives as receptor tyrosine kinase ihibitors
|
|
US20050222171A1
(en)
|
2004-01-22 |
2005-10-06 |
Guido Bold |
Organic compounds
|
|
PE20051089A1
(es)
|
2004-01-22 |
2006-01-25 |
Novartis Ag |
Derivados de pirazolo [1,5-a] pirimidin-7-il-amina como inhibidores de quinasa de proteina
|
|
WO2005099363A2
(en)
|
2004-03-26 |
2005-10-27 |
Whitehead Institute For Biomedical Research |
Methods of diagnosing, preventing and treating cancer metastasis
|
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
|
CA2575808A1
(en)
|
2004-08-02 |
2006-02-16 |
Osi Pharmaceuticals, Inc. |
Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
|
|
PE20060664A1
(es)
|
2004-09-15 |
2006-08-04 |
Novartis Ag |
Amidas biciclicas como inhibidores de cinasa
|
|
WO2006050076A1
(en)
|
2004-10-29 |
2006-05-11 |
Janssen Pharmaceutica, N.V. |
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
|
|
EP1838298A4
(en)
|
2004-12-17 |
2009-03-04 |
Univ Pennsylvania |
STYLENE DERIVATIVES AND THEIR USE OF THE BINDING AND IMAGE DISPLAY OF AMYLOID PLAQUE
|
|
DE102005003687A1
(de)
|
2005-01-26 |
2006-07-27 |
Sphingo Tec Gmbh |
Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation
|
|
GB0501999D0
(en)
|
2005-02-01 |
2005-03-09 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
|
EP1848506A2
(en)
|
2005-02-18 |
2007-10-31 |
Attenuon, LLC |
Pyrimidine-fused diazepine derivatives and indole-fused pteridines
|
|
GB0507575D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
|
EP1874731A4
(en)
|
2005-04-15 |
2009-08-05 |
Cylene Pharmaceuticals Inc |
CHINOBENZOXAZINANALOGA AND METHOD FOR THE APPLICATION
|
|
AU2006248780B2
(en)
|
2005-05-16 |
2010-06-03 |
Astrazeneca Ab |
Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
|
|
US20100047777A1
(en)
|
2005-05-26 |
2010-02-25 |
The Johns Hopkins University |
Methods for identifying mutations in coding and non-coding dna
|
|
CN101233129A
(zh)
|
2005-05-31 |
2008-07-30 |
普法尔家族联合企业（1996.7.9） |
取代的联芳杂环衍生物作为蛋白激酶抑制剂治疗癌症及其他疾病
|
|
US7541367B2
(en)
|
2005-05-31 |
2009-06-02 |
Janssen Pharmaceutica, N.V. |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
|
|
ITRM20050290A1
(it)
|
2005-06-07 |
2006-12-08 |
Lay Line Genomics Spa |
Uso di molecole in grado di inibire il legame tra ngf e il suo recettore trka come analgesici ad effetto prolungato.
|
|
WO2007002433A1
(en)
|
2005-06-22 |
2007-01-04 |
Plexxikon, Inc. |
Pyrrolo [2, 3-b] pyridine derivatives as protein kinase inhibitors
|
|
GB0515026D0
(en)
|
2005-07-21 |
2005-08-31 |
Novartis Ag |
Organic compounds
|
|
AU2006284096B2
(en)
|
2005-08-25 |
2012-03-29 |
Avro Life Sciences, Inc. |
Polymer conjugates of K-252a and derivatives thereof
|
|
US7803806B2
(en)
|
2005-11-03 |
2010-09-28 |
Sgx Pharmaceuticals, Inc. |
Pyrimidinyl-thiophene kinase modulators
|
|
US20070149523A1
(en)
|
2005-11-14 |
2007-06-28 |
Jan Ehlert |
Thiazole Analogues and Uses Thereof
|
|
EP1785420A1
(en)
|
2005-11-14 |
2007-05-16 |
4Sc Ag |
Thiazole analogues and uses thereof
|
|
WO2007057399A2
(en)
|
2005-11-15 |
2007-05-24 |
Boehringer Ingelheim International Gmbh |
Treatment of cancer with indole derivatives
|
|
WO2007057397A1
(en)
|
2005-11-15 |
2007-05-24 |
Boehringer Ingelheim International Gmbh |
Treatment of cancer
|
|
GB0524436D0
(en)
|
2005-11-30 |
2006-01-11 |
Novartis Ag |
Organic compounds
|
|
US7795273B2
(en)
|
2005-12-08 |
2010-09-14 |
Novartis Ag |
Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors
|
|
EP1968579A1
(en)
|
2005-12-30 |
2008-09-17 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
|
US20090227598A1
(en)
|
2006-01-24 |
2009-09-10 |
Buser-Doepner Carolyn A |
Ret Tyrosine Kinase Inhibition
|
|
AU2007209689B2
(en)
|
2006-01-27 |
2012-03-15 |
Shanghai Hengrui Pharmaceutical Co. Ltd. |
Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
|
|
RU2008140382A
(ru)
|
2006-03-16 |
2010-04-27 |
Новартис АГ (CH) |
Гетероциклические органические соединения, например, для лечения меланомы
|
|
TWI409267B
(zh)
|
2006-03-17 |
2013-09-21 |
Ambit Biosciences Corp |
治療疾病用之咪唑并噻唑化合物
|
|
CN101410387B
(zh)
|
2006-03-27 |
2013-12-18 |
内尔维阿诺医学科学有限公司 |
作为激酶抑制剂的吡啶基-和嘧啶基-取代的吡咯-、噻吩-和呋喃-衍生物
|
|
EP2018167A4
(en)
|
2006-05-15 |
2010-07-14 |
Irm Llc |
COMPOSITIONS AND METHODS AS INHIBITORS OF FGF RECEPTOR KINASES
|
|
CA2652442C
(en)
|
2006-05-18 |
2014-12-09 |
Eisai R & D Management Co., Ltd. |
Antitumor agent for thyroid cancer
|
|
US8063225B2
(en)
|
2006-08-14 |
2011-11-22 |
Chembridge Corporation |
Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
|
|
US20110195072A1
(en)
|
2006-09-12 |
2011-08-11 |
Anne Boulay |
Non-neuroendocrine cancer therapy
|
|
AU2007294686B2
(en)
|
2006-09-15 |
2013-10-31 |
Equinox Sciences, Llc |
Kinase inhibitor compounds
|
|
US20120225057A1
(en)
|
2006-10-11 |
2012-09-06 |
Deciphera Pharmaceuticals, Llc |
Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
|
|
EP1918291A1
(en)
|
2006-10-30 |
2008-05-07 |
Novartis AG |
3-Aminocarbonyl-substituted fused pyrazolo-derivatives as protein kinase modulators
|
|
EP3048099A3
(en)
|
2006-11-15 |
2016-09-21 |
YM BioSciences Australia Pty Ltd |
Inhibitors of kinase activity
|
|
TW200833690A
(en)
*
|
2006-12-15 |
2008-08-16 |
Bayer Schering Pharma Ag |
3-H-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
|
|
WO2008079909A1
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Pyrrolo [2,3-b] pyridines as kinase modulators
|
|
PE20121126A1
(es)
|
2006-12-21 |
2012-08-24 |
Plexxikon Inc |
Compuestos pirrolo [2,3-b] piridinas como moduladores de quinasa
|
|
CA2673736A1
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
US20080199426A1
(en)
|
2007-01-11 |
2008-08-21 |
Sukhatme Vikas P |
Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders
|
|
JP2010516692A
(ja)
|
2007-01-19 |
2010-05-20 |
バイエル・ヘルスケア・エルエルシー |
化学療法剤に対し抵抗性を有する癌の処置
|
|
US20080234267A1
(en)
|
2007-03-20 |
2008-09-25 |
Karen Elizabeth Lackey |
Compounds and Methods of Treatment
|
|
US20110189167A1
(en)
*
|
2007-04-20 |
2011-08-04 |
Flynn Daniel L |
Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases
|
|
EP2152688A1
(en)
|
2007-05-04 |
2010-02-17 |
Irm Llc |
Compounds and compositions as c-kit and pdgfr kinase inhibitors
|
|
WO2008138184A1
(fr)
|
2007-05-14 |
2008-11-20 |
Shanghai Hengrui Pharmaceutical Co.Ltd. |
Dérivés de pyrrolo-azacycles, leur procédé de fabrication et leur utilisation en tant qu'inhibiteurs de protéine kinases
|
|
WO2009003136A1
(en)
|
2007-06-26 |
2008-12-31 |
Rigel Pharmaceuticals, Inc. |
Substituted pyrimidine-2, 4 -diamines for treating cell proliferative disorders
|
|
BRPI0814818A2
(pt)
|
2007-07-09 |
2019-09-10 |
Astrazeneca Ab |
composto, uso de um composto, métodos para produzir um efeito anti-proliferativo e um efeito inibitório de mtor quinase em uma animal de sangue quente, método para tratar doenças, e, composição farmacêutica
|
|
US20100209488A1
(en)
|
2007-07-16 |
2010-08-19 |
The Regents Of The University Of California |
Protein kinase modulating compounds and methods for making and using them
|
|
BRPI0814423B1
(pt)
|
2007-07-17 |
2022-04-19 |
Plexxikon, Inc |
Compostos que modulam quinase e composição farmacêutica compreendendo os mesmos
|
|
CN101801958B
(zh)
|
2007-07-19 |
2014-01-29 |
默沙东公司 |
作为蛋白质激酶抑制剂的杂环酰胺化合物
|
|
PL2176231T3
(pl)
|
2007-07-20 |
2017-04-28 |
Nerviano Medical Sciences S.R.L. |
Podstawione pochodne indazolu aktywne jako inhibitory kinazy
|
|
WO2009017838A2
(en)
|
2007-08-01 |
2009-02-05 |
Exelixis, Inc. |
Combinations of jak-2 inhibitors and other agents
|
|
JP5703466B2
(ja)
|
2007-08-07 |
2015-04-22 |
パーデュー・リサーチ・ファウンデーションＰｕｒｄｕｅ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ |
キナーゼ阻害薬およびその使用
|
|
EP2025678A1
(en)
|
2007-08-17 |
2009-02-18 |
Oncalis AG |
Pyrazolo[3,4-d]pyrimidine compounds and their use as modulators of protein kinase
|
|
WO2009042646A1
(en)
|
2007-09-24 |
2009-04-02 |
Curis, Inc. |
Anti-proliferative agents
|
|
JP2011501760A
(ja)
|
2007-10-23 |
2011-01-13 |
ノバルティス アーゲー |
呼吸器疾患の処置のためのｔｒｋｂ抗体の使用
|
|
EP2215091B1
(en)
|
2007-12-04 |
2016-03-30 |
Nerviano Medical Sciences S.r.l. |
Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors
|
|
CN101459004B
(zh)
|
2007-12-14 |
2011-02-09 |
深圳富泰宏精密工业有限公司 |
电子装置的按键面板结构及制造该按键面板结构的方法
|
|
CN102015769B
(zh)
|
2008-01-17 |
2014-12-10 |
Irm责任有限公司 |
改进的抗-trkb抗体
|
|
US20090227556A1
(en)
|
2008-01-31 |
2009-09-10 |
Eisai R&D Management Co., Ltd. |
Receptor tyrosine kinase inhibitors comprising pyridine and pyrimidine derivatives
|
|
TW200938542A
(en)
|
2008-02-01 |
2009-09-16 |
Irm Llc |
Compounds and compositions as kinase inhibitors
|
|
US20090209496A1
(en)
|
2008-02-15 |
2009-08-20 |
David Chaplin |
Methods and compositions for enhancing the efficacy of rtk inhibitors
|
|
US8822500B2
(en)
|
2008-03-19 |
2014-09-02 |
Chembridge Corporation |
Tyrosine kinase inhibitors
|
|
JP5628145B2
(ja)
|
2008-03-19 |
2014-11-19 |
ケムブリッジ・コーポレーション |
新規チロシンキナーゼ阻害剤
|
|
JP5767101B2
(ja)
|
2008-03-28 |
2015-08-19 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
キナーゼ阻害剤として活性な３，４−ジヒドロ−２ｈ−ピラジノ［１，２−ａ］インドール−１−オン誘導体、これらの調製方法、およびこれらを含む医薬組成物
|
|
WO2009143018A2
(en)
|
2008-05-19 |
2009-11-26 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
PE20091846A1
(es)
|
2008-05-19 |
2009-12-16 |
Plexxikon Inc |
DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
|
|
ES2554513T3
(es)
|
2008-05-23 |
2015-12-21 |
Novartis Ag |
Derivados de quinolinas y quinoxalinas como inhibidores de la proteína tirosina quinasa
|
|
JP5767965B2
(ja)
|
2008-06-10 |
2015-08-26 |
プレキシコン インコーポレーテッドＰｌｅｘｘｉｋｏｎ Ｉｎｃ． |
キナーゼを調節する５ｈ−ピロロ［２，３−ｂ］ピラジン誘導体、およびその適応症
|
|
US20110212053A1
(en)
|
2008-06-19 |
2011-09-01 |
Dapeng Qian |
Phosphatidylinositol 3 kinase inhibitors
|
|
EP2313091A4
(en)
|
2008-07-14 |
2012-04-04 |
Univ Kingston |
PHARMACEUTICAL COMPOSITIONS WITH RET-HEMMERN AND METHOD FOR THE TREATMENT OF CANCER
|
|
JO3041B1
(ar)
*
|
2008-07-25 |
2016-09-05 |
Galapagos Nv |
مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية
|
|
US8946226B2
(en)
|
2008-07-29 |
2015-02-03 |
Nerviano Medical Sciences S.R.L. |
Use of CDK inhibitor for the treatment of glioma
|
|
CN102100126B
(zh)
|
2008-09-01 |
2014-04-16 |
夏普株式会社 |
有机电致发光面板、有机电致发光显示器、有机电致发光照明装置和它们的制造方法
|
|
US20100075916A1
(en)
|
2008-09-05 |
2010-03-25 |
Auspex Pharmaceuticals, Inc. |
Substituted quinazoline inhibitors of growth factor receptor tyrosine kinases
|
|
EP2161271A1
(en)
|
2008-09-08 |
2010-03-10 |
Università Degli Studi Di Milano - Bicocca |
Alpha-carboline inhibitors of NMP-ALK, RET, and Bcr-Abl
|
|
ES2536730T3
(es)
|
2008-09-19 |
2015-05-28 |
Nerviano Medical Sciences S.R.L. |
Derivados de 3,4-dihidro-2H-pirrolo[1,2-a]pirazin-1-ona
|
|
SI2350075T1
(sl)
|
2008-09-22 |
2014-06-30 |
Array Biopharma, Inc. |
Substituirane imidazo (1,2b)piridazinske spojine kot Trk kinazni inhibitorji
|
|
WO2010036629A2
(en)
|
2008-09-26 |
2010-04-01 |
National Health Research Institutes |
Fused multicyclic compounds as protein kinase inhibitors
|
|
SG10201914059WA
(en)
|
2008-10-22 |
2020-03-30 |
Array Biopharma Inc |
Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors
|
|
JP5686736B2
(ja)
|
2008-11-06 |
2015-03-18 |
アムビト ビオスシエンセス コルポラチオン |
プロテインキナーゼモジュレーターとしてのイミダゾロチアゾール化合物
|
|
US8912194B2
(en)
|
2008-11-24 |
2014-12-16 |
Nerviano Medical Sciences S.R.L. |
CDK inhibitor for the treatment of mesothelioma
|
|
KR101061599B1
(ko)
|
2008-12-05 |
2011-09-02 |
한국과학기술연구원 |
비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물
|
|
JO3265B1
(ar)
|
2008-12-09 |
2018-09-16 |
Novartis Ag |
مثبطات بيريديلوكسى اندولات vegf-r2 واستخدامها لعلاج المرض
|
|
CN105859639A
(zh)
*
|
2009-03-18 |
2016-08-17 |
雷斯韦洛吉克斯公司 |
新的抗炎剂
|
|
WO2010111527A1
(en)
|
2009-03-26 |
2010-09-30 |
Plexxikon, Inc. |
Pyrazolo [ 3, 4 -b] pyridines as kinase inhibitors and their medical use
|
|
TWI410418B
(zh)
|
2009-04-29 |
2013-10-01 |
Ind Tech Res Inst |
氮雜薁化合物、藥學組合物與抑制一細胞中蛋白質激酶之活性的方法
|
|
EP3009428B1
(en)
|
2009-05-08 |
2018-02-21 |
Astellas Pharma Inc. |
Diamino heterocyclic carboxamide compound
|
|
EP2440058A4
(en)
|
2009-06-12 |
2012-11-21 |
Dana Farber Cancer Inst Inc |
MELTED HETEROCYCLIC COMPOUNDS AND APPLICATIONS THEREOF
|
|
ES2679379T3
(es)
|
2009-06-15 |
2018-08-24 |
Nerviano Medical Sciences S.R.L. |
Derivados de pirimidinilpirrolopiridinona sustituidos, proceso para su preparación y su uso como inhibidores de cinasa
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
HRP20190016T1
(hr)
|
2009-08-17 |
2019-03-08 |
Intellikine, Llc |
Heterociklički spojevi i njihova upotreba
|
|
KR101256018B1
(ko)
|
2009-08-20 |
2013-04-18 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 갖는 1,3,6-치환된 인돌 화합물
|
|
FR2951172B1
(fr)
|
2009-10-13 |
2014-09-26 |
Pf Medicament |
Derives pyrazolopyridines en tant qu'agent anticancereux
|
|
KR101147550B1
(ko)
|
2009-10-22 |
2012-05-17 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 가지는 2,7-치환된 티에노［3,2-ｄ］피리미딘 화합물
|
|
KR101116756B1
(ko)
|
2009-10-27 |
2012-03-13 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 갖는 신규의 1,6-치환된 인돌 화합물
|
|
US8404677B2
(en)
|
2009-10-29 |
2013-03-26 |
Genosco |
Kinase inhibitors
|
|
WO2011060295A1
(en)
|
2009-11-13 |
2011-05-19 |
Genosco |
Kinase inhibitors
|
|
KR101094446B1
(ko)
|
2009-11-19 |
2011-12-15 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 가지는 2,4,7-치환된 티에노［3,2-ｄ］피리미딘 화합물
|
|
CA2784807C
(en)
|
2009-12-29 |
2021-12-14 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
|
US8772279B2
(en)
|
2010-01-29 |
2014-07-08 |
Nerviano Medical Sciences S.R.L. |
6,7-dihydroimidazo[1,5-a]pyrazin-8(5H)-one derivatives as protein kinase modulators
|
|
EP2528925B1
(en)
|
2010-01-29 |
2017-07-05 |
Hanmi Science Co., Ltd. |
THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY ON PROTEIN KINASES
|
|
KR101483215B1
(ko)
|
2010-01-29 |
2015-01-16 |
한미약품 주식회사 |
단백질 키나아제 저해활성을 갖는 비시클릭 헤테로아릴 유도체
|
|
ES2594927T3
(es)
|
2010-02-18 |
2016-12-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Métodos para prevenir las metástasis cancerosas
|
|
TWI619713B
(zh)
|
2010-04-21 |
2018-04-01 |
普雷辛肯公司 |
用於激酶調節的化合物和方法及其適應症
|
|
EP2918588B1
(en)
|
2010-05-20 |
2017-05-03 |
Array Biopharma, Inc. |
Macrocyclic compounds as TRK kinase inhibitors
|
|
UY33597A
(es)
|
2010-09-09 |
2012-04-30 |
Irm Llc |
Compuestos y composiciones como inhibidores de la trk
|
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
|
WO2012047017A2
(ko)
|
2010-10-05 |
2012-04-12 |
크리스탈지노믹스(주) |
2,3-디히드로-이소인돌-1-온 유도체 및 이를 포함하는 조성물
|
|
JP2014005206A
(ja)
|
2010-10-22 |
2014-01-16 |
Astellas Pharma Inc |
アリールアミノヘテロ環カルボキサミド化合物
|
|
WO2012101029A1
(en)
|
2011-01-26 |
2012-08-02 |
Nerviano Medical Sciences S.R.L. |
Tricyclic derivatives, process for their preparation and their use as kinase inhibitors
|
|
EP2668190B1
(en)
|
2011-01-26 |
2016-08-17 |
Nerviano Medical Sciences S.r.l. |
Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
|
|
CN102093421B
(zh)
|
2011-01-28 |
2014-07-02 |
北京康辰药业有限公司 |
一种含磷取代基的喹啉类化合物及其制备方法、以及含有该化合物的药物组合物及其应用
|
|
AU2012214762B2
(en)
|
2011-02-07 |
2015-08-13 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
EP2678336B1
(en)
|
2011-02-24 |
2016-04-20 |
Nerviano Medical Sciences S.r.l. |
Thiazolylphenyl-benzenesulfonamido derivatives as kinase inhibitors
|
|
JP5959541B2
(ja)
|
2011-02-25 |
2016-08-02 |
ノバルティス アーゲー |
Ｔｒｋ阻害剤としてのピラゾロ［１，５−ａ］ピリジン
|
|
WO2012135631A1
(en)
|
2011-03-30 |
2012-10-04 |
Arrien Pharmaeuticals Llc |
Substituted 5-(pyrazin-2-yl)-1h-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors
|
|
PT2693881T
(pt)
|
2011-04-01 |
2019-12-09 |
Univ Utah Res Found |
Análogos de n-fenilpirimidin-2-amina substituídos como inibidores da axl cinase
|
|
US9284298B2
(en)
|
2011-04-11 |
2016-03-15 |
Nerviano Medical Sciences S.R.L. |
Pyrazolyl-pyrimidine derivatives as kinase inhibitors
|
|
EP2699564B1
(en)
|
2011-04-19 |
2016-12-14 |
Nerviano Medical Sciences S.r.l. |
Substituted pyrimidinyl-pyrroles active as kinase inhibitors
|
|
AR086042A1
(es)
*
|
2011-04-28 |
2013-11-13 |
Galapagos Nv |
Compuesto util para el tratamiento de enfermedades degenerativas e inflamatorias y composicion farmaceutica
|
|
ES2611779T3
(es)
|
2011-05-12 |
2017-05-10 |
Nerviano Medical Sciences S.R.L. |
Derivados de indazol sustituidos activos como inhibidores de quinasas
|
|
SI2712358T1
(sl)
|
2011-05-13 |
2017-03-31 |
Array Biopharma, Inc. |
Spojine pirolidinil sečnine, pirolidinil tiosečnine in pirolidinil gvanidina kot inhibitorji kinaze trka
|
|
RU2477723C2
(ru)
|
2011-06-16 |
2013-03-20 |
Общество С Ограниченной Ответственностью "Фьюжн Фарма" |
Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
|
|
CN102827073A
(zh)
*
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
|
JP6016915B2
(ja)
|
2011-07-28 |
2016-10-26 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
キナーゼ阻害剤として活性なアルキニル置換ピリミジニルピロール
|
|
WO2013016720A2
(en)
|
2011-07-28 |
2013-01-31 |
Gerinda Therapeutics, Inc. |
Novel substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases
|
|
EP2740742B1
(en)
|
2011-08-04 |
2018-03-14 |
National Cancer Center |
Fusion gene of kif5b gene and ret gene, and method for determining effectiveness of cancer treatment targeting fusion gene
|
|
WO2013028817A1
(en)
|
2011-08-23 |
2013-02-28 |
Foundation Medicine , Inc. |
Novel kif5b-ret fusion molecules and uses thereof
|
|
MX370814B
(es)
|
2011-09-02 |
2020-01-08 |
Univ California |
Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas.
|
|
WO2013036232A2
(en)
|
2011-09-08 |
2013-03-14 |
Deciphera Pharmaceuticals, Llc |
Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
|
|
WO2013042137A1
(en)
|
2011-09-19 |
2013-03-28 |
Aurigene Discovery Technologies Limited |
Bicyclic heterocycles as irak4 inhibitors
|
|
CN102408411B
(zh)
|
2011-09-19 |
2014-10-22 |
北京康辰药业股份有限公司 |
一种含喹啉基的羟肟酸类化合物及其制备方法、以及含有该化合物的药物组合物及其应用
|
|
ES2639064T3
(es)
|
2011-10-07 |
2017-10-25 |
Nerviano Medical Sciences S.R.L. |
Derivados de 3,4-dihidropirrolo[1,2-a]pirazin-1(2h)-ona sustituidos como inhibidores de cinasa
|
|
EP2788350B1
(en)
|
2011-10-07 |
2017-12-06 |
Nerviano Medical Sciences S.r.l. |
4-ALKYL SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS
|
|
US20150306086A1
(en)
|
2011-11-14 |
2015-10-29 |
Tesaro, Inc. |
Modulating certain tyrosine kinases
|
|
EP2749642A4
(en)
|
2011-11-30 |
2015-03-04 |
Nat Cancer Ct |
INDUCED MALIGNE STEM CELLS
|
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
|
BR112014015720B1
(pt)
|
2011-12-30 |
2020-03-17 |
Hanmi Pharm. Co., Ltd. |
Derivados de tieno[3,2-d]pirimidina, composição farmacêutica e uso dos mesmos para a prevenção ou tratamento de uma doença causada por ativação anormal de uma proteína quinase
|
|
JP2015109806A
(ja)
|
2012-03-22 |
2015-06-18 |
アステラス製薬株式会社 |
新規ｒｅｔ融合体の検出法
|
|
ES2605388T3
(es)
|
2012-04-26 |
2017-03-14 |
Ono Pharmaceutical Co., Ltd. |
Compuesto inhibidor de Trk
|
|
AU2013259267A1
(en)
|
2012-05-10 |
2014-11-06 |
Synta Pharmaceuticals Corp. |
Treating cancer with Hsp90 inhibitory compounds
|
|
ES2751944T3
(es)
|
2012-05-23 |
2020-04-02 |
Nerviano Medical Sciences Srl |
Proceso para la preparación de N-[5-(3,5-difluoro-bencil)-1H-indazol-3-il]-4-(4-metil-piperazin-1-il)-2-(tetrahidro-piran-4-ilamino)-benzamida
|
|
TWI585088B
(zh)
|
2012-06-04 |
2017-06-01 |
第一三共股份有限公司 |
作爲激酶抑制劑之咪唑并［１，２－ｂ］嗒衍生物
|
|
US8802697B2
(en)
|
2012-07-11 |
2014-08-12 |
Blueprint Medicines Corporation |
Inhibitors of the fibroblast growth factor receptor
|
|
CN104428463B
(zh)
|
2012-07-13 |
2018-07-24 |
奥的斯电梯公司 |
包括纤维的皮带
|
|
JPWO2014017491A1
(ja)
|
2012-07-26 |
2016-07-11 |
国立研究開発法人国立がん研究センター |
Ｃｅｐ５５遺伝子とｒｅｔ遺伝子との融合遺伝子
|
|
DK2880025T3
(en)
|
2012-08-02 |
2019-03-18 |
Nerviano Medical Sciences Srl |
SUBSTITUTED PYROLES ACTIVE AS KINase INHIBITORS
|
|
US20140121239A1
(en)
|
2012-09-07 |
2014-05-01 |
Exelixis, Inc. |
Method of treating lung adenocarcinoma
|
|
SG11201502211QA
(en)
|
2012-09-25 |
2015-05-28 |
Chugai Pharmaceutical Co Ltd |
Ret inhibitor
|
|
ES2755772T3
(es)
|
2012-11-07 |
2020-04-23 |
Nerviano Medical Sciences Srl |
Pirimidinil y piridinilpirrolopiridinonas sustituidas, proceso para su preparación y su uso como inhibidores de cinasas
|
|
AR093457A1
(es)
|
2012-11-12 |
2015-06-10 |
Cephalon Inc |
Derivados de bendamustina y metodos para utilizarlos
|
|
WO2014078322A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
US9828360B2
(en)
|
2012-11-13 |
2017-11-28 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
WO2014078331A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(arylalkyl)-n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
ES2664331T3
(es)
|
2012-11-13 |
2018-04-19 |
Array Biopharma, Inc. |
Compuestos de N-pirrolidinilo, N'-pirazolilurea, tiourea, guanidina y cianoguanidina como inhibidores de la cinasa Trka
|
|
WO2014078328A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-bicyclic aryl,n'-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
US9790178B2
(en)
|
2012-11-13 |
2017-10-17 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
WO2014078408A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
US9809578B2
(en)
|
2012-11-13 |
2017-11-07 |
Array Biopharma Inc. |
Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trkA kinase inhibitors
|
|
WO2014078325A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(monocyclic aryl),n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
RU2664541C2
(ru)
|
2012-11-13 |
2018-08-20 |
Эррэй Биофарма Инк. |
Бициклические соединения мочевины, тиомочевины, гуанидина и цианогуанидина, пригодные для лечения боли
|
|
JP2016502536A
(ja)
|
2012-11-29 |
2016-01-28 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
腫瘍転移を防止し、がんを処置および予後診断し、推定転移阻害剤である薬剤を同定する方法
|
|
CN103848785B
(zh)
|
2012-12-04 |
2016-07-13 |
上海医药集团股份有限公司 |
一类氘代3-氰基喹啉类化合物、其药用组合物、制备方法及其用途
|
|
FR3000494B1
(fr)
|
2012-12-28 |
2015-08-21 |
Oribase Pharma |
Nouveaux derives d'azaindoles en tant qu'inhibiteurs de proteines kinases
|
|
FR3000493A1
(fr)
|
2012-12-28 |
2014-07-04 |
Oribase Pharma |
Nouveaux inhibiteurs de proteines kinases
|
|
RU2671847C2
(ru)
|
2012-12-28 |
2018-11-07 |
Кристалдженомикс, Инк. |
Производные 2,3-дигидро-изоиндол-1-она и способы их применения в качестве ингибиторов тирозинкиназы брутона
|
|
FR3000492B1
(fr)
|
2012-12-28 |
2015-09-11 |
Oribase Pharma |
Nouveaux derives azaindole en tant qu'inhibiteurs multikinases
|
|
HUE042591T2
(hu)
|
2013-02-19 |
2019-07-29 |
Ono Pharmaceutical Co |
TRK-gátló vegyület
|
|
US20160151461A1
(en)
|
2013-03-14 |
2016-06-02 |
The Trustees Of The University Of Pennsylvania |
Cardio-Metabolic and Vascular Effects of GLP-1 Metabolites
|
|
US8937071B2
(en)
|
2013-03-15 |
2015-01-20 |
Glaxosmithkline Intellectual Property Development Limited |
Compounds as rearranged during transfection (RET) inhibitors
|
|
PE20151538A1
(es)
|
2013-03-15 |
2015-11-18 |
Glaxosmithkline Ip Dev Ltd |
Nuevos compuestos como inhibidores de reorganizado durante la transfeccion (ret)
|
|
WO2014160521A1
(en)
|
2013-03-15 |
2014-10-02 |
Blueprint Medicines Corporation |
Piperazine derivatives and their use as kit modulators
|
|
WO2014184069A1
(en)
|
2013-05-14 |
2014-11-20 |
Nerviano Medical Sciences S.R.L. |
Pyrrolo[2,3-d]pyrimidine derivatives, process for their preparation and their use as kinase inhibitors
|
|
CA2912568A1
(en)
|
2013-05-30 |
2014-12-04 |
Plexxikon Inc. |
Compounds for kinase modulation, and indications therefor
|
|
WO2015017528A1
(en)
|
2013-07-30 |
2015-02-05 |
Blueprint Medicines Corporation |
Pik3c2g fusions
|
|
EP3027655B1
(en)
|
2013-07-30 |
2019-08-21 |
Blueprint Medicines Corporation |
Ntrk2 fusions
|
|
US20150057335A1
(en)
|
2013-08-20 |
2015-02-26 |
National Cancer Center |
Novel fusion genes identified in lung cancer
|
|
RU2016111675A
(ru)
|
2013-08-30 |
2017-10-04 |
Эмбит Байосайенсиз Корпорейшн |
Соединения биарилацетамида и способы их применения
|
|
ES2675355T3
(es)
*
|
2013-09-30 |
2018-07-10 |
Korea Research Institute Of Chemical Technology |
Derivados de triazolopirazina como inhibidores de tirosina cinasa
|
|
ES2683127T3
(es)
|
2013-10-17 |
2018-09-25 |
Blueprint Medicines Corporation |
Composiciones útiles para tratar trastornos relacionados con la KIT
|
|
WO2015058129A1
(en)
|
2013-10-17 |
2015-04-23 |
Blueprint Medicines Corporation |
Compositions useful for treating disorders related to kit
|
|
AU2014339972B9
(en)
|
2013-10-25 |
2019-05-30 |
Blueprint Medicines Corporation |
Inhibitors of the fibroblast growth factor receptor
|
|
GB201321146D0
(en)
|
2013-11-29 |
2014-01-15 |
Cancer Rec Tech Ltd |
Quinazoline compounds
|
|
EP3076966A2
(en)
|
2013-12-02 |
2016-10-12 |
BerGenBio AS |
Use of kinase inhibitors
|
|
WO2015108992A1
(en)
|
2014-01-15 |
2015-07-23 |
Blueprint Medicines Corporation |
Heterobicyclic compounds and their use as fgfr4 receptor inhibitors
|
|
EP3636649B1
(en)
|
2014-01-24 |
2024-02-14 |
Turning Point Therapeutics, Inc. |
Diaryl macrocycles as modulators of protein kinases
|
|
EP3738952A1
(en)
|
2014-02-14 |
2020-11-18 |
Exelixis, Inc. |
Crystalline solid forms of n-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
|
|
US10231965B2
(en)
|
2014-02-20 |
2019-03-19 |
Ignyta, Inc. |
Molecules for administration to ROS1 mutant cancer cells
|
|
US20170044622A1
(en)
|
2014-04-18 |
2017-02-16 |
Blueprint Medicines Corporation |
Pik3ca fusions
|
|
WO2015161277A1
(en)
|
2014-04-18 |
2015-10-22 |
Blueprint Medicines Corporation |
Met fusions
|
|
PT3154959T
(pt)
|
2014-05-15 |
2019-09-24 |
Array Biopharma Inc |
1-((3s,4r)-4-(3-fluorofenil)-1-(2-metoxietil)-pirrolidin-3-il)-3-(4-metil-3-(2-metilpirimidin-5-il)-1-fenil-1h-pirazol-5-il)ureia como inibidor da cinase trka
|
|
US10246750B2
(en)
|
2014-06-10 |
2019-04-02 |
Blueprint Medicines Corporation |
Method for detection of a TECR:PKN1 or an ANXA4:PKN1 gene fusion
|
|
WO2015191666A2
(en)
|
2014-06-10 |
2015-12-17 |
Blueprint Medicines Corporation |
Raf1 fusions
|
|
EP3169809B1
(en)
|
2014-07-17 |
2020-04-29 |
Blueprint Medicines Corporation |
Prkc fusions
|
|
EP3169804B3
(en)
|
2014-07-17 |
2019-09-18 |
Blueprint Medicines Corporation |
Fgr fusions
|
|
AU2015291522B2
(en)
|
2014-07-17 |
2018-12-06 |
Sunshine Lake Pharma Co., Ltd. |
Substituted urea derivatives and pharmaceutical uses thereof
|
|
WO2016011144A1
(en)
|
2014-07-17 |
2016-01-21 |
Blueprint Medicines Corporation |
Tert fusions
|
|
WO2016022569A1
(en)
|
2014-08-04 |
2016-02-11 |
Blueprint Medicines Corporation |
Compositions useful for treating disorders related to kit
|
|
KR20170042591A
(ko)
|
2014-08-18 |
2017-04-19 |
오노 야꾸힝 고교 가부시키가이샤 |
Trk 저해 화합물의 산부가염
|
|
WO2016038519A1
(en)
|
2014-09-08 |
2016-03-17 |
Glaxosmithkline Intellectual Property Development Limited |
Crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-n-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide
|
|
US9879021B2
(en)
|
2014-09-10 |
2018-01-30 |
Glaxosmithkline Intellectual Property Development Limited |
Compounds as rearranged during transfection (RET) inhibitors
|
|
PL3191450T3
(pl)
|
2014-09-10 |
2019-08-30 |
Glaxosmithkline Intellectual Property Development Limited |
Pochodne pirydonu jako inhibitory kinazy rearanżowanej podczas transfekcji (ret)
|
|
TWI538914B
(zh)
|
2014-10-03 |
2016-06-21 |
國立交通大學 |
蛋白質激酶之選擇性抑制劑、其醫藥組成物及其用途
|
|
CA2967125C
(en)
|
2014-11-14 |
2022-10-25 |
Nerviano Medical Sciences S.R.L. |
6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors
|
|
US10799505B2
(en)
|
2014-11-16 |
2020-10-13 |
Array Biopharma, Inc. |
Crystalline form of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate
|
|
WO2016081450A1
(en)
|
2014-11-18 |
2016-05-26 |
Blueprint Medicines Corporation |
Prkacb fusions
|
|
EP3233840B1
(en)
|
2014-12-16 |
2018-11-21 |
Eudendron S.r.l. |
Heterocyclic derivatives modulating activity of certain protein kinases
|
|
US10202365B2
(en)
|
2015-02-06 |
2019-02-12 |
Blueprint Medicines Corporation |
2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
|
|
KR101675984B1
(ko)
|
2015-02-23 |
2016-11-14 |
한양대학교 에리카산학협력단 |
티에노디아제핀 유도체 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 포함하는 약학적 조성물
|
|
WO2016141169A1
(en)
*
|
2015-03-03 |
2016-09-09 |
Caris Mpi, Inc. |
Molecular profiling for cancer
|
|
US10364247B2
(en)
|
2015-04-21 |
2019-07-30 |
Ruijin Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine |
Preparation and use of novel protein kinase inhibitors
|
|
GB201512365D0
(en)
|
2015-07-15 |
2015-08-19 |
King S College London |
Novel therapy
|
|
DK3322706T3
(da)
|
2015-07-16 |
2021-02-01 |
Array Biopharma Inc |
Substituerede pyrazolo[1,5-a]pyridin-forbindelser som ret-kinaseinhibitorer
|
|
EP3120851A1
(en)
|
2015-07-21 |
2017-01-25 |
Pangaea Biotech S.L. |
4-amino-6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)-pyrido[2,3-d]pyrimidin-7(8h)-one for treatment of solid cancers
|
|
KR101766194B1
(ko)
|
2015-08-07 |
2017-08-10 |
한국과학기술연구원 |
RET 키나아제 저해제인 신규 3-(이속사졸-3-일)-피라졸로[3,4-d]피리미딘-4-아민 화합물
|
|
WO2017027883A1
(en)
|
2015-08-13 |
2017-02-16 |
San Diego State University Research Foundation |
Atropisomerism for increased kinase inhibitor selectivity
|
|
MA41559A
(fr)
|
2015-09-08 |
2017-12-26 |
Taiho Pharmaceutical Co Ltd |
Composé de pyrimidine condensé ou un sel de celui-ci
|
|
WO2017049462A1
(zh)
|
2015-09-22 |
2017-03-30 |
合肥中科普瑞昇生物医药科技有限公司 |
一类新型的flt3激酶抑制剂及其用途
|
|
CN105255927B
(zh)
|
2015-09-30 |
2018-07-27 |
温州医科大学附属第一医院 |
一种kiaa1217-ret融合基因
|
|
EA038890B1
(ru)
|
2015-11-02 |
2021-11-03 |
Блюпринт Медсинс Корпорейшн |
Ингибиторы ret
|
|
US20190002988A1
(en)
|
2015-12-08 |
2019-01-03 |
Boehringer Ingelheim International Gmbh |
Method of using a ret fusion gene as a biomarker to select non small cell lung cancer (nsclc) and thyroid cancer patients for a cancer treatment
|
|
JP6871869B2
(ja)
|
2016-01-15 |
2021-05-19 |
公益財団法人がん研究会 |
新規融合体及びその検出法
|
|
TWI620748B
(zh)
|
2016-02-05 |
2018-04-11 |
National Health Research Institutes |
氨基噻唑化合物及其用途
|
|
EP3269370B1
(en)
|
2016-02-23 |
2020-01-08 |
Taiho Pharmaceutical Co., Ltd. |
Novel condensed pyrimidine compound or salt thereof
|
|
WO2017145050A1
(en)
|
2016-02-23 |
2017-08-31 |
Glaxosmithkline Intellectual Property Development Limited |
Pyridylpyridone derivative useful as a ret kinase inhibitor in the treatment of ibs and cancer
|
|
AR107912A1
(es)
|
2016-03-17 |
2018-06-28 |
Blueprint Medicines Corp |
Inhibidores de ret
|
|
US10045991B2
(en)
|
2016-04-04 |
2018-08-14 |
Loxo Oncology, Inc. |
Methods of treating pediatric cancers
|
|
SG11201808878UA
(en)
|
2016-04-15 |
2018-11-29 |
Cancer Research Tech Ltd |
Heterocyclic compounds as ret kinase inhibitors
|
|
EP3442535B1
(en)
|
2016-04-15 |
2022-06-01 |
Cancer Research Technology Limited |
Heterocyclic compounds as ret kinase inhibitors
|
|
TWI704148B
(zh)
|
2016-10-10 |
2020-09-11 |
美商亞雷生物製藥股份有限公司 |
作為ｒｅｔ激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
|
|
JOP20190077A1
(ar)
|
2016-10-10 |
2019-04-09 |
Array Biopharma Inc |
مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret
|